Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 4, 2009, Pages 407-414

  Lee, V W Y ^a   Fan, C S Y ^b   Li, A W M ^b   Chau, A C Y ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

Cholesterol management; Clinical pharmacy

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HONG KONG; HUMAN; HYPERLIPIDEMIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHARMACIST; PHYSICIAN; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

AGED; ANTILIPEMIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; HYPERLIPIDEMIAS; INTERPROFESSIONAL RELATIONS; LIFE STYLE; MALE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 67651251930     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01024.x     Document Type: Article

References (30)

1. WHO (2004) Cardiovascular disease: prevention and control. Geneva : World health Organization.
2. Census and Statistics Department (2005-2006) Ten Leading Causes of Death 2004. Available at: http://www.chp.gov.hk/data.asp?lang=en&cat=4&dns- sumID=117&id=27&pid=10&ppid (accessed 16 October 2008).
3. Causes of Death from Heart Diseases by Age and Sex 2004. Available at: http://www.ha.org.hk (accessed 16 October 2008).
4. Bild DE, Detrano R, Peterson D et al. (2005) Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation, 111, 1313 1320.
5. Lee VWY, Chan WK, Lam NLC et al. (2005) Cost of acute myocardial infarction in Hong Kong. Disease Management & Health Outcomes, 13, 281 285.
6. Wun YT, Tang JL, Chao DVK (2001) Evidence-based management of dyslipiaemia: Hong Kong family physicians' perspective. Hong Kong Practitioner, 23, 191 200.
7. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine, 339 : 1349 1357.
8. Elderly health services disease prevention and control division, Department of health, Hong Kong Special Administrative Region Topical Health Report No. 3. Elderly health. Department of Health, Hong Kong, 2004, 44, p. Special Volume. Available at: http://www.chp.gov.hk/files/pdf/grp-ehc-en- 2004052100.pdf (accessed 20 June 2008).
9. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2002) Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Final report (NCEP ATP - III). Circulation, 106, 3143 3418.
10. Pang RW, Tam S, Janus ED et al. (2006) Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment. Atherosclerosis, 184, 438 445.
11. Grundy SM, Cleeman JI, Merz CNB et al. (2004) Implications of recent clinical trials for the National cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110, 227 239.
12. Cohen MV, Byrne MJ, Levine B et al. (1991) Low rate of treatment of hypercholesterolemia by cardiologists in suspected and proven coronary artery diseases. Circulation, 83, 1294 1304.
13. Lee VWY, Chan WK, Lee BSC et al. (2008) Cholesterol goal attainment among coronary heart disease patients in Hong Kong. Value in Health, 11, S91 S98.
14. Insull W (1997) The problem of compliance to cholesterol altering therapy. Journal of Internal Medicine, 241, 317 325.
15. Benner JS, Glynn RJ, Mogun H et al. (2002) Long-term persistence in use of statin therapy in elderly patients. Journal of American Medical Association, 288, 455 461.
16. LaRosa JH, LaRosa JC (2000) Enhancing drug compliance in lipid-lowering treatment. Archives of Family Medicine, 9, 1169 1175.
17. Simpson RJ (2006) Challenges for improving medication adherence. Journal of American Medical Association, 296, 2614 2616.
18. Clark PM, Karagoz T, Apikoglu-Rabus S et al. (2007) Effect of pharmacist-led patient education on adherence to tuberculosis treatment. American Journal of Health-System Pharmacy, 64, 497 506.
19. Bosmans JE, Brook OH, Hein PJ et al. (2007) Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants. Pharmacoeconomics, 25, 25 37.
20. Dole EJ, Murawski MM, Adikohe AB et al. (2007) Provision of pain management by a pharmacist with prescribing authority. American Journal of Health-System Pharmacy, 64, 85 89.
21. Elliott RA (2006) Poor adherence to anti-inflammatory medication in asthma: reasons, challenges, and strategies for improved disease management. Disease Management & Health Outcomes, 14, 223 233.
22. Bogden PE, Koontz LM, Williamson P et al. (1997) The physician and pharmacist team: an effective approach to cholesterol reduction. Journal of General Internal Medicine, 12, 158 164.
23. Olson KL, Rasmussen J, Sandhoff BG et al. (2005) Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Archives of Internal Medicine, 165, 49 54.
24. Lee SSC, Cheung PYP, Chow MSS (2004) Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. Journal of Clinical Pharmacology, 44, 632 639.
25. Bozovich M, Rubino CM, Edmunds J (2000) Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy, 20, 1375 1383.
26. Bluml BM, McKenney JM, Cziraky MJ (2000) Pharmaceutical care services and results in project IMPACT: hyperlipidaemia. Journal of American Pharmaceutical Association, 40, 157 165.
27. Avorn J, Monnett J, Lacour A et al. (1998) Relationship between patient characteristics and high persistence. JAMA, 279, 1458 1462.
28. Faulkner MA, Wadibia EC, Lucas BD et al. (2000) Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy, 20, 410 416.
29. Wu JYF, Leung WYS, Chang S et al. (2006) Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial. British Medical Journal, 333, 522.
30. Prochaska JO, Velicer WF (1997) The transtheoretical model of health behavior change. American Journal of Health Promotion, 12, 38 48.